Clinical Trial Update: Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis [Phase 1]

View source ↗

Summary

Phase 1 safety update on intravenous infusion of PDA001, a human placenta-derived cell therapy, for adults with Stage II or Stage III pulmonary sarcoidosis; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcoidosis

Drugs mentioned

• PDA001

Snippet

Sponsor: Celularity Incorporated | Conditions: Stage 2 Pulmonary Sarcoidosis, Stage 3 Pulmonary Sarcoidosis | Phase 1 | Status: TERMINATED